Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Raj Makkar Added: 6 months ago
EuroPCR 25 - Post-hoc anlysis outcomes from under-expansion of the ACURATE neo2 valve in severe aortic stenosis (AS) patients show under-expansion was associated with higher rates of death, stroke or rehospitalisation.We are joined by Dr Raj Makkar (Cedars-Sinai Heart Institute, Los Angeles, US) to discuss findings from the post-hoc analysis of the ACURATE IDE study (NCT03735667; Boston… View more
Added: 4 months ago Source:  Radcliffe Cardiology
A post hoc analysis of the ACURATE IDE trial has found that underexpansion of the ACURATE neo2 transcatheter heart valve (THV) was associated with a higher rate of adverse clinical outcomes at one year.¹ The original trial failed to demonstrate non-inferiority of the ACURATE neo2 valve compared with contemporary commercial valves for the primary endpoint of all-cause mortality, stroke, or… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 3 months ago
ESC Congress 2025 – Day 3 of ESC Congress 2025 continued to deliver groundbreaking research with pivotal studies shaping the future of cardiovascular medicine.Interventional cardiologists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) provide their comprehensive breakdown of the most impactful hot line trial results from the day's sessions.Day 3 Highlights… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 4 months ago
Expert interventionalists, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve.ESC Congress 2025 Hot Line Trials Discussed:00:25 DOUBLE-CHOICE03:03 VANTAGE05:03 VICTOR06:28 VICTORIA07:58 DIGIT HF10:19 DAPA ACT HF-TIMI… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Consultant Medical Oncologist, Royal Marsden Hospital, London, UK
Dr Alicia Okines is a consultant in medical oncology at the Royal Marsden NHS Foundation Trust and the team leader for the Breast Cancer Systemic Therapy Trials team.Dr Okines studied pharmacology at the University of Sheffield, where she also pursued her medical training. Throughout her oncology residency at The Royal Marsden Hospital and the Institute of Cancer Research, she earned an MD(Res),… View more
Added: 4 months ago Source:  ESC Congress 2025 Scientific Programme
Ten hot line sessions have been announced for ESC Congress 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Hot Line 1Friday 29th August, 11:00am – 12:00pm (CEST)POTCAST – a Randomized Controlled Trial of Arrhythmia prevention using targeted plasma potassium levels in ICD Patients – Presented by Christian… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 4 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more